Etiqueta: muscular dystrophy
-
US FDA Green Lights Second Duchenne’s Muscular Dystrophy Patient To Receive Human Umbilical Cord Stem Cells In US
(PRWEB) MAY 26, 2016 After several promising treatments in Panama using stem cell technology developed by Medistem Panama Inc. at the City of Knowledge in Panama, a 6 year-old Duchenne’s muscular dystrophy patient received his first umbilical cord tissue-derived mesenchymal stem cells in the US earlier this year following FDA approval of a second application…
-
Duchenne’s Patient Ryan Benton Discusses His Experience with Stem Cell Therapy
Ryan Benton is the first patient in the United States to receive human umbilical cord-derived mesenchymal stem cell therapy for Duchenne’s muscular dystrophy. The US FDA granted Ryan this trial under compassionate use. Ryan first began treatments at the Stem Cell Institute in Panama before being able to receive treatments in his hometown of Wichita,…
-
Histostem Works With Korean Government Agency to Provide Cord Blood Storage for Multicultural Families
The US company Amstem through subsidiary signed a partnership agreement with the Songpa-Gu Office of the Seoul Metropolitan Government, to provide umbilical cord blood banking to multicultural families for up to 15 years. Cord blood is currently used for treatment of patients with blood disorders such as leukemias as an alternative to bone marrow. Unfortunately…
